Solara Active

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE624Z01016
  • NSEID: SOLARA
  • BSEID: 541540
INR
568.40
-13.6 (-2.34%)
BSENSE

Jun 18

BSE+NSE Vol: 1.27 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003017,
    "name": "Solara Active",
    "stock_name": "Solara Active",
    "full_name": "Solara Active Pharma Sciences Ltd",
    "name_url": "stocks-analysis/solara-active",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "568.40",
    "chg": -13.6,
    "chgp": "-2.34%",
    "dir": -1,
    "prev_price": "582.00",
    "mcapval": "2,716.05 Cr",
    "mcap": "Small Cap",
    "scripcode": 541540,
    "symbol": "SOLARA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE624Z01016",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.27 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/solara-active-1003017-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Solara Active Pharma spurts after reporting turnaround Q4 perfromance",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-15 14:52:46",
        "description": "Solara Active Pharma spurts after reporting turnaround Q4 perfromance  Business Standard..."
      },
      {
        "title": "Solara Active Pharma Sciences reports consolidated net profit of Rs 9.60 crore in the March 2026 quarter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-15 14:52:15",
        "description": "Solara Active Pharma Sciences reports consolidated net profit of Rs 9.60 crore in the March 2026 quarter  Business Standard..."
      },
      {
        "title": "Why Solara Active Pharma Sciences shares surged 18% today",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-15 14:38:52",
        "description": "Why Solara Active Pharma Sciences shares surged 18% today  Business Today..."
      }
    ],
    "total": 3,
    "sid": "1003017",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/solara-active-pharma-sciences-1003017"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "16-Jun-2026",
      "details": "Allotment of 70000 Equity Shares pursuant to exercise of Options under Solara Employee Stock Option Plan 2024",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "16-Jun-2026",
      "details": "Allotment of 2250 Equity shares pursuant to exercise of Options under Solara Employee Stock Option Plan 2018",
      "source": "BSE"
    },
    {
      "caption": "Clarification On Volume Movement",
      "datetime": "10-Jun-2026",
      "details": "Clarification in relation to the Email received from BSE on June 10 2026 on Volume movement.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has declared <strong>30%</strong> dividend, ex-date: 18 Aug 21",
          "dt": "2021-08-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has announced <strong>1:3</strong> rights issue, ex-date: 15 May 24",
          "dt": "2024-05-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

16-Jun-2026 | Source : BSE

Allotment of 70000 Equity Shares pursuant to exercise of Options under Solara Employee Stock Option Plan 2024

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

16-Jun-2026 | Source : BSE

Allotment of 2250 Equity shares pursuant to exercise of Options under Solara Employee Stock Option Plan 2018

Clarification On Volume Movement

10-Jun-2026 | Source : BSE

Clarification in relation to the Email received from BSE on June 10 2026 on Volume movement.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Solara Active Pharma Sciences Ltd has declared 30% dividend, ex-date: 18 Aug 21

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Solara Active Pharma Sciences Ltd has announced 1:3 rights issue, ex-date: 15 May 24